---
title: "U.S. Treasury Secretary Becerra: No opinion on whether the president can use (monetary) policy reaso"
description: "U.S. Treasury Secretary Becerra: No opinion on whether the president can use (monetary) policy reasons to dismiss the Federal Reserve Chairman"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/274852600.md"
published_at: "2026-02-04T18:00:25.000Z"
---

# U.S. Treasury Secretary Becerra: No opinion on whether the president can use (monetary) policy reaso

> U.S. Treasury Secretary Becerra: No opinion on whether the president can use (monetary) policy reasons to dismiss the Federal Reserve Chairman

U.S. Treasury Secretary Becerra: No opinion on whether the president can use (monetary) policy reasons to dismiss the Federal Reserve Chairman

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Hims & Hers Stock Stumbles - Cautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences | Hims & Hers Health Inc. (NYSE:HIMS) shares fell 6.90% to $14.44 in premarket trading after reporting mixed Q4 earnings.  | [Link](https://longbridge.com/en/news/276744332.md) |
| First Solar In The Spotlight Ahead Of Q4 Earnings | First Solar, Inc. (NASDAQ:FSLR) is trending ahead of its Q4 earnings report, expected to show EPS of $5.15 and revenue o | [Link](https://longbridge.com/en/news/276757729.md) |
| QUOTES-Analysts' comments after Anthropic unveils new plug-ins | On February 24, Anthropic introduced 10 new plug-ins aimed at enhancing business operations in investment banking, wealt | [Link](https://longbridge.com/en/news/276760305.md) |
| Roblox CEO Baszucki David Reports Open Market Sale Of 4,045 Shares Of Class A Common Stock On Feb 20 | Roblox CEO David Baszucki reported the open market sale of 4,045 shares of Class A common stock on February 20 at an ave | [Link](https://longbridge.com/en/news/276799143.md) |
| BUZZ-Larimar jumps on FDA's 'breakthrough' tag for neurological disorder therapy | Shares of therapy developer Larimar Therapeuticsjump 32% to $3.71 premarketCo says the U.S. FDA granted a breakthrough d | [Link](https://longbridge.com/en/news/276742755.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.